AKRO AKERO THERAPEUTICS INC

Ownership history in Caption Management, LLC  ·  30 quarters on record

This page tracks every 13F SEC filing in which Caption Management, LLC reported a position in AKERO THERAPEUTICS INC (AKRO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.16% (2023 Q3)
Avg. % of fund
0.04%
First filed
2020 Q1
Last filed
2025 Q3
Quarters held
30
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 130,000 +100,000 +333.3% 0.05% $6.2M
2025 Q3 REDUCED 30,000 -9,500 -24.1% 0.01% $1.4M
2025 Q3 ADDED 39,500 +8,162 +26.0% 0.01% $1.9M
2025 Q2 REDUCED 31,338 -108,662 -77.6% 0.02% $1.7M
26 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)

Other funds also holding AKRO

As of 2025 Q4 — sorted by position size

Nebula Research & Development LLC 0.07% IFP Advisors, Inc 3Y 7Y 0.0%
← Back to Caption Management, LLC Holdings